PA
ABX

PharVision Advisers’s Abacus Global Management ABX Stock Holding History

PharVision Advisers’s Portfolio ABX Stock Details ABX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26,083
Closed -$149K – 668
2025
Q3 		$149K Buy
26,083
+4,446
+21% +$26.4K 0.08% 573
2025
Q2 		$111K Buy
+21,637
New +$160K 0.16% 247

Other funds holding ABX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MCA
Mendon Capital Advisors Key Largo, Florida $258M AUM 21.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

PharVision Advisers's ABX Position: Q4 2025 in Review

PharVision Advisers sold out of Abacus Global Management (ABX) in Q4 2025, closing a stake of 26,083 shares — an estimated $149K sold.

PharVision Advisers first reported a position in ABX in Q2 2025 and held it in 2 quarters. The position peaked at $149K in Q3 2025. 120 funds tracked by Wall St. Rank hold ABX as of Q4 2025.

  • PharVision Advisers reported no remaining Abacus Global Management position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 26,083 Abacus Global Management shares in Q4 2025, an estimated $149K.
  • PharVision Advisers first reported a position in Abacus Global Management in Q2 2025 and held it in 2 quarters.
  • PharVision Advisers's Abacus Global Management position peaked at $149K in Q3 2025.
  • 120 funds tracked by Wall St. Rank held Abacus Global Management as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.